In an adult without liver disease, renal impairment, or drug hypersensitivity, do omeprazole, esomeprazole, or famotidine interfere with levothyroxine absorption, and how should the medications be timed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levothyroxine Interactions with Acid-Suppressing Medications

Omeprazole and esomeprazole (proton pump inhibitors) may reduce levothyroxine absorption and should be separated from levothyroxine by at least 4 hours, while famotidine (H2-antagonist) does not appear to significantly interfere with levothyroxine absorption based on controlled studies. 1

Evidence for Proton Pump Inhibitors (Omeprazole/Esomeprazole)

Proton pump inhibitors are recognized as clinically significant interacting agents that decrease levothyroxine absorption. 2 The mechanism involves reduced gastric acidity, which impairs the dissolution and absorption of levothyroxine in the gastrointestinal tract. 3

Clinical Implications:

  • Patients taking levothyroxine with PPIs concomitantly may require increased levothyroxine doses to maintain euthyroid status. 4, 2
  • Closer monitoring of thyroid-stimulating hormone (TSH) and free T4 levels is necessary when PPIs are initiated or discontinued in patients on levothyroxine. 2
  • The interaction is established and clinically significant, requiring dose adjustments in many patients. 2

Evidence for H2-Antagonists (Famotidine)

A controlled study in 30 healthy volunteers found no significant differences in levothyroxine absorption after 1 week of famotidine therapy. 1 Peak hormone levels and area under the curve (AUC) measurements for T4, T3, and free T4 index remained unchanged before and after famotidine administration. 1

Important Caveat:

While this single controlled study showed no interaction, the evidence for H2-antagonists remains contradictory in the broader literature, with some sources suggesting potential interactions. 2 However, the direct experimental evidence from controlled testing favors no clinically significant interaction with famotidine specifically. 1

Medication Timing Recommendations

When PPIs cannot be avoided, separate levothyroxine administration from the PPI by at least 4 hours to minimize absorption interference. 4 The optimal approach is:

  • Take levothyroxine on an empty stomach, typically in the morning upon waking 5
  • Administer the PPI at least 4 hours after levothyroxine 4
  • Consider taking levothyroxine at bedtime (at least 3-4 hours after the last meal) if morning administration conflicts with other medications 2

For famotidine, based on available evidence, strict separation may not be necessary, though taking levothyroxine on an empty stomach remains the standard recommendation. 1

Monitoring Strategy

When initiating or discontinuing acid-suppressing medications in patients on levothyroxine:

  • Check TSH and free T4 levels 6-12 weeks after any change in acid-suppressing therapy 5
  • The long half-life of levothyroxine (approximately 7 days) means dose adjustments should only be considered after 6-12 weeks of stable therapy 5
  • Be alert for signs of hypothyroidism (fatigue, weight gain, cold intolerance) or hyperthyroidism (tachycardia, tremor, sweating) during medication transitions 5

Additional Considerations

Other medications that significantly impair levothyroxine absorption and require separation include calcium supplements, iron supplements, cholestyramine, colesevelam, and aluminum-containing antacids. 4, 2 These should be taken at least 4 hours apart from levothyroxine. 4

Gastrointestinal conditions that reduce gastric acidity (atrophic gastritis, H. pylori infection) may also impair levothyroxine absorption, making the addition of PPIs particularly problematic in these patients. 2

References

Research

The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption.

Thyroid : official journal of the American Thyroid Association, 2008

Research

Levothyroxine absorption in health and disease, and new therapeutic perspectives.

European review for medical and pharmacological sciences, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What are the potential drug interactions with Levothyroxine (thyroid hormone replacement medication)?
What is the time frame for Synthroid (levothyroxine) to take effect?
What is the next step for a patient with hypothyroidism and elevated Thyroid-Stimulating Hormone (TSH) levels, who cannot tolerate oral Levothyroxine (thyroxine) due to diarrhea?
What can I do to improve my absorption of Synthroid (levothyroxine)?
Is levothyroxine (Synthroid) absorption from capsules better than from tablets in patients on high-dose pantoprazole?
What is the appropriate management for a patient who develops herpes zoster after receiving the shingles vaccine (Shingrix recombinant zoster vaccine or Zostavax live attenuated vaccine), including antiviral therapy, pain control, and whether to complete the vaccine series?
What is bretamine?
Interpret the following laboratory results—electrolytes Na 142 mmol/L, K 4.5 mmol/L, Cl 106 mmol/L, CO₂ 29 mmol/L, anion gap 7; renal function BUN 15 mg/dL, creatinine 0.79 mg/dL, eGFR 82 mL/min/1.73 m², BUN/creatinine ratio 19; calcium 9.6 mg/dL; liver panel AST 111 U/L, ALT 47 U/L, alkaline phosphatase 103 U/L, total protein 7.1 g/dL, albumin 4.6 g/dL, globulin 2.5 g/dL, bilirubin 0.6 mg/dL—what is the clinical interpretation and recommended next steps?
My 1‑year‑old child receiving systemic corticosteroids now has dyspnea, persistent fever, decreased appetite and diarrhea while being treated with Tyrol (acetaminophen); what is the appropriate management?
What is the appropriate antibiotic choice and dosing for an otherwise healthy 4-year-old child weighing 15.6 kg?
What are the risk factors for deep vein thrombosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.